STOCK TITAN

Goodrx Holdings, Inc. Stock Price, News & Analysis

GDRX Nasdaq

Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.

GoodRx Holdings, Inc. (NASDAQ: GDRX) is widely described as the leading platform for medication savings in the U.S., and its news flow reflects that role at the intersection of digital healthcare, pharmacy, and pharmaceutical manufacturers. Company announcements highlight new partnerships, product launches, and financial updates that shape how consumers, pharmacies, and manufacturers approach prescription affordability.

News about GoodRx often covers collaborations with major healthcare players. Examples include the RxSmartSaver program powered by GoodRx at national and regional retail pharmacies, which brings brand medication savings directly to the pharmacy counter, and an exclusive partnership with Surescripts that integrates GoodRx discounted cash prices into Script Corner, a patient experience product focused on prescription price transparency.

GoodRx also issues press releases on new consumer offerings and subscriptions. Recent updates describe GoodRx for Weight Loss, a telemedicine subscription for GLP-1 weight management treatment, and GoodRx for Hair Loss, a subscription program for men that combines virtual consultations, prescriptions for oral finasteride or oral minoxidil when appropriate, and discreet home delivery. Additional news highlights defined cash prices for medications such as Repatha, Ozempic, Wegovy, and the Wegovy pill at tens of thousands of pharmacies nationwide via GoodRx.

Investors and observers can also find earnings-related news, including quarterly financial results, guidance commentary, and participation in healthcare conferences. Together, these updates provide insight into GoodRx’s strategy across prescription transactions, subscriptions, pharma manufacturer solutions, and telehealth. For anyone tracking GDRX, this news page offers a focused view of how the company is evolving its platform, expanding partnerships, and addressing medication affordability across the U.S. healthcare system.

Rhea-AI Summary

GoodRx Holdings (Nasdaq: GDRX) plans to release its Q2 2021 financial results on August 12, 2021, before U.S. markets open. A conference call will follow at 5:00 a.m. PT (8:00 a.m. ET) to discuss the results and business outlook. A shareholder letter and detailed financial results will be available on their investor relations website. GoodRx is recognized as America's leading resource for healthcare savings, having helped Americans save over $30 billion since 2011 and is the most downloaded medical app for the last three years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.42%
Tags
conferences earnings
-
Rhea-AI Summary

GoodRx (NASDAQ: GDRX) has partnered with DoorDash (NYSE: DASH) to offer discounted access to its GoodRx Gold subscription program for DoorDash drivers, known as 'Dashers.' This partnership allows Dashers to save up to 90% on over 1,000 medications and provides online doctor visit discounts along with free mail delivery for prescriptions. GoodRx Gold can save individuals an average of $2,600 annually when filling 2 prescriptions monthly. This initiative aims to enhance healthcare access for the growing freelance workforce in the U.S., which comprises 35% of all workers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.35%
Tags
partnership
-
Rhea-AI Summary

GoodRx (NASDAQ: GDRX) released a report detailing its positive impact on American healthcare, showcasing significant savings for patients. In 2020, GoodRx users saved an average of 79% on medications, equating to around $30 billion in total savings. The platform has improved medication adherence, contributing to the prevention of over 1,000 hospitalizations and saving nearly 500 lives. Additionally, over 20% of Americans reported struggling with basic necessities due to medication costs, highlighting the importance of GoodRx in alleviating financial burdens.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
none
Rhea-AI Summary

GoodRx Holdings Inc. (Nasdaq: GDRX) announced its financial results for the first quarter of 2021, showcasing its role as a leader in healthcare savings in the U.S. The company has facilitated over $30 billion in savings since 2011. A conference call to discuss these results and the business outlook is scheduled for May 13, 2021, at 2:00 PM PT. GoodRx emphasizes its services, including affordable prescriptions, telehealth, and lab tests, making it the #1 most downloaded medical app for the last three years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.55%
Tags
-
Rhea-AI Summary

GoodRx Holdings (Nasdaq: GDRX), a leader in healthcare savings, announced upcoming presentations at two virtual investor conferences. The RBC Capital Markets Global Healthcare Conference will take place on May 19 at 1:15 p.m. PT, followed by the Evercore ISI TMT Conference on June 7 at 9:30 a.m. PT. Live webcasts and archived recordings of these presentations can be accessed via GoodRx's Investor Relations website. GoodRx has saved Americans over $25 billion since 2011 and remains the most downloaded medical app for three consecutive years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
conferences
-
Rhea-AI Summary

GoodRx (Nasdaq: GDRX) has launched an integrated offering with Sanofi to simplify access to manufacturer discounts for insulin and other prescriptions. This collaboration aims to assist uninsured and commercially insured diabetes patients, potentially saving Americans up to $260 million in 2021. Patients can now find and claim Sanofi discounts directly on the GoodRx platform. Currently, insured patients can pay between $0 to $10 for select drugs, while uninsured patients face a flat fee of $99 monthly for specific insulins. This initiative is expected to enhance affordability for millions of diabetes patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.99%
Tags
none
Rhea-AI Summary

GoodRx (NASDAQ: GDRX) has completed the acquisition of HealthiNation, enhancing its healthcare resources. With a vast library of premium health videos, HealthiNation enables GoodRx to deliver superior content and information to consumers while offering manufacturers targeted engagement opportunities. This move aligns with GoodRx’s strategy to bolster its Manufacturing Solutions business and improve health outcomes for users. The acquisition highlights GoodRx's commitment to affordable healthcare solutions, leveraging HealthiNation's expertise for greater market reach.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.16%
Tags
-
Rhea-AI Summary

GoodRx Holdings Inc. (GDRX) announced its first quarter 2021 financial results will be released after U.S. markets close on May 13, 2021. A conference call will follow at 2:00 p.m. PT to discuss the results and future outlook. GoodRx has helped Americans save over $25 billion since 2011, becoming the top downloaded medical app for the past three years. The press release will also include a link to a shareholder letter and results on its investor relations site.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
conferences earnings
-
Rhea-AI Summary

GoodRx (GDRX) has launched a Vaccine Guide to assist users in navigating the rollout of the COVID-19 vaccine. Collaborating with the CDC and VaccineFinder, GoodRx tracks vaccine availability at over 50,000 locations, including pharmacies and clinics. The guide allows consumers to find vaccination appointments and the types of vaccines available. Notably, more than 1.8 million Americans have subscribed for text alerts on local eligibility and updates. GoodRx has saved Americans over $25 billion in healthcare costs since 2011, becoming the #1 downloaded medical app in the last three years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.71%
Tags
covid-19
Rhea-AI Summary

GoodRx Holdings Inc. (Nasdaq: GDRX) announced its fourth quarter and full year 2020 financial results, emphasizing its role as a leading healthcare savings resource. The company has facilitated over $25 billion in savings for Americans since 2011. Investors can access the full results and a shareholder letter on the company's investor relations website. A conference call is scheduled for March 11, 2021, at 2:00 p.m. PT to discuss these results further.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.42%
Tags

FAQ

What is the current stock price of Goodrx Holdings (GDRX)?

The current stock price of Goodrx Holdings (GDRX) is $2.21 as of February 9, 2026.

What is the market cap of Goodrx Holdings (GDRX)?

The market cap of Goodrx Holdings (GDRX) is approximately 828.2M.
Goodrx Holdings, Inc.

Nasdaq:GDRX

GDRX Rankings

GDRX Stock Data

828.22M
87.85M
12.67%
62.83%
1.92%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
SANTA MONICA

GDRX RSS Feed